Through analysis of the mutanome and immune status of lung adenocarcinoma cells, Norman and colleagues revealed that the tumor cells expressed multiple neoepitopes and a weak immune response was detected after PD-1 inhibition; however, injection of a modified oncolytic adenovirus elicited CD8+ T cell responses specific for neoantigens [66]. This evidence concerns the gene CD8A and neoplasm.